2nd Apr 2013 16:05
SHIRE PLC - Director/PDMR ShareholdingSHIRE PLC - Director/PDMR Shareholding
PR Newswire
London, April 2
Director/PDMR Share Dealings
April 2, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG), (the "Company") announcesthat it was notified on March 28, 2013 that on the same day the Ordinary Shares("Shares") and American Depository Shares ("ADSs") of the Company, as set outbelow, had been awarded under the Shire Executive Annual Incentive Plan("EAIP") to Persons Discharging Managerial Responsibility ("PDMRs"). The Sharesand ADSs were acquired on March 28, 2013 at prices of £19.94 per Share and$90.00 per ADS.
Type of Number of Security Shares/ADSs Angus Russell (Chief Executive Officer) ADSs 3,123 Graham Hetherington (Chief Financial Shares 4,504Officer) Sylvie Gregoire ADSs 1,262 Jeffrey Jonas ADSs 932 Tatjana May Shares 2,702The awards will normally be released to participants after a period of threeyears. One ADS is equal to three Shares.
In addition, the Company was notified on April 2, 2013 of the release of thefollowing ADSs and Shares awarded in 2010 under the EAIP.
Type of Number of Number of Shares Security Shares/ADSs /ADSs sold to released satisfy tax liabilities Angus Russell (Chief Executive ADSs 7,421 6,176Officer) Graham Hetherington (Chief Financial Shares 12,569 6,552 Officer) Tatjana May Shares 7,515 3,918On April 1 and April 2, 2013, sufficient ADSs and Shares were soldrespectively, to satisfy tax liabilities as set out above. The ADSs and Shareswere sold at prices of $90.9568 per ADS and £19.94 per Share.
The above transactions in Shares and ADSs took place on the London StockExchange and NASDAQ respectively.
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a)of the Disclosure and Transparency Rules.
Tony GuthrieDeputy Company SecretaryFor further information please contact:
Investor Relations Eric Rojas [email protected] +1 781 482 0999 Sarah Elton-Farr [email protected] +44 1256 894157 Notes to editorsShire enables people with life-altering conditions to lead better lives.
Through our deep understanding of patients' needs, we develop and providehealthcare in the areas of:
* Behavioral Health and Gastro Intestinal conditions * Rare Diseases * Regenerative Medicineas well as other symptomatic conditions treated by specialist physicians.
We aspire to imagine and lead the future of healthcare, creating value forpatients, physicians, policymakers, payors and our shareholders.
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX Press Releasewww.shire.com
Related Shares:
Shire